Low dose colchicine tablets can be taken to control the symptoms during the acute stage of gout. During the acute attack of gout, patients may experience severe joint pain, redness and swelling of the joints, limited movement and other symptoms due to inflammation of the joints and surrounding tissues. Colchicine tablets can alleviate the symptoms of gout during the acute phase by inhibiting neutrophil chemotaxis, reducing the release of prostaglandins and leukotrienes, and inhibiting the production of interleukin-6, and other pathways. Common adverse drug reactions to colchicine include abdominal pain, diarrhea, loss of appetite, hair loss, and liver damage. Patients who are allergic to colchicine drug components, patients with myelodysplasia, patients with hepatic or renal insufficiency, and pregnant or lactating women are contraindicated to use this drug treatment. Precautions: In the event of vomiting, diarrhea and other reactions, the dosage should be reduced, and in serious cases, the drug should be stopped immediately. Bone marrow hematopoietic insufficiency, severe heart disease, renal insufficiency and gastrointestinal disorders should be used with caution. During the period of use of the drug, check the blood picture and liver and kidney functions regularly. In addition, oral uric acid-lowering drugs such as febuxostat and benzbromarone should be taken during the remission period of gout. Colchicine should be used under the guidance of a physician, and gout patients are advised to go to the rheumatology and immunology departments of regular hospitals for detailed consultation.